Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.370
-0.060 (-4.20%)
At close: Jul 16, 2026, 4:00 PM EDT
1.390
+0.020 (1.46%)
After-hours: Jul 16, 2026, 5:43 PM EDT
Ocugen Employees
Ocugen had 116 employees as of December 31, 2025. The number of employees increased by 21 or 22.11% compared to the previous year.
Employees
116
Change (1Y)
21
Growth (1Y)
22.11%
Revenue / Employee
$38,491
Profits / Employee
-$617,871
Market Cap
463.77M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 116 | 21 | 22.11% |
| Dec 31, 2024 | 95 | 30 | 46.15% |
| Dec 31, 2023 | 65 | -19 | -22.62% |
| Dec 31, 2022 | 84 | 28 | 50.00% |
| Dec 31, 2021 | 56 | 41 | 273.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| ProKidney | 231 |
| Kyverna Therapeutics | 129 |
| Artiva Biotherapeutics | 106 |
| Verastem | 102 |
| Silence Therapeutics | 88 |
| Editas Medicine | 87 |
| Rezolute | 68 |
OCGN News
- 3 days ago - Ocugen announces $4M OCU400 license agreement with Roots Pharmaceutical - TheFly
- 3 days ago - Ocugen, Inc. Announces Binding Term Sheet with Roots Pharmaceutical to License OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa - GlobeNewsWire
- 6 days ago - Ocugen Transcript: Piper Sandler Virtual Ophthalmology Day - Transcripts
- 15 days ago - Ocugen to Participate in Upcoming July Industry Conferences - GlobeNewsWire
- 5 weeks ago - Ocugen Transcript: AGM 2026 - Transcripts
- 6 weeks ago - Ocugen Transcript: Noble Capital Markets June 2026 Emerging Growth Virtual Equity Conference - Transcripts
- 6 weeks ago - Ocugen to Participate in Upcoming June Investor and Industry Conferences - GlobeNewsWire
- 7 weeks ago - Ocugen price target lowered to $11 from $12 at Canaccord - TheFly